The associate director of research at Lyell Immunopharma discussed the company’s programs and newest technologies aimed at solid tumors.
Rachel Lynn, PhD
Advertisement
Articles by Rachel Lynn, PhD
Advertisement
The associate director of research at Lyell Immunopharma discussed the company’s programs and newest technologies aimed at solid tumors.
